IL6 and glioma: As suggested in other types of cancer, the reduction of PBDCs in our patients may be sustained partly by DC recruitment into the tumor microenvironment, and partly by tumor-derived cytokines, such as VEGF and IL-6 that are produced by glioma cells (26, 36) and inhibit DC maturation in the bone marrow (37).